Genetic and Epigenetic Silencing of the Beclin 1 Gene in Sporadic Breast Tumors

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2010 Mar 17

PMID 20230646

Citations 63

Authors

Zidong Li

Bo Chen

Yiqing Wu

Feng Jin

Yongjing Xia

Xiangjun Liu

Affiliations

Soon will be listed here.

Abstract

Background: Beclin 1, an important autophagy-related protein in human cells, is involved in cell death and cell survival. Beclin 1 mapped to human chromosome 17q21. It is widely expressed in normal mammary epithelial cells. Although down-regulated expression with mono-allelic deletions of beclin 1 gene was frequently observed in breast tumors, whether there was other regulatory mechanism of beclin 1 was to be investigated. We studied the expression of beclin 1 and explored the possible regulatory mechanisms on its expression in breast tumors.

Methods: 20 pairs of tumors and adjacent normal tissues from patients with sporadic breast invasive ductal cancer (IDCs) were collected. The mRNA expression of beclin 1 was detected by real-time quantitative RT-PCR. Loss of heterozygosity (LOH) was determined by real-time quantitative PCR and microsatellite methods. The protein expression of beclin 1, p53, BRCA1 and BRCA2 was assessed by immunohistochemistry. CpG islands in 5' genomic region of beclin 1 gene were identified using MethylPrimer Program. Sodium bisulfite sequencing was used in examining the methylation status of each CpG island.

Results: Decreased beclin 1 mRNA expression was detected in 70% of the breast tumors, and the protein levels were co-related to the mRNA levels. Expression of beclin 1 mRNA was demonstrated to be much higher in the BRCA1 positive tumors than that in the BRCA1 negative ones. Loss of heterozygosity was detected in more than 45% of the breast tumors, and a dense cluster of CpG islands was found from the 5' end to the intron 2 of the beclin 1 gene. Methylation analysis showed that the promoter and the intron 2 of beclin 1 were aberrantly methylated in the tumors with decreased expression.

Conclusions: These data indicated that LOH and aberrant DNA methylation might be the possible reasons of the decreased expression of beclin 1 in the breast tumors. The findings here shed some new light on the regulatory mechanisms of beclin 1 in breast cancer.

Citing Articles

Calycosin alleviates ovariectomy-induced osteoporosis by promoting BMSCs autophagy via the PI3K/Akt/mTOR pathway.

Xiang S, Luo Y, Liu W, Tang C, Zhu T, Tian L Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40087184 DOI: 10.1007/s00210-025-04009-x.

Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review.

Panda V, Mishra B, Mahapatra S, Swain B, Malhotra D, Saha S Cancers (Basel). 2025; 17(2).

PMID: 39858015 PMC: 11763662. DOI: 10.3390/cancers17020234.

Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2.

Celada S, Li G, Celada L, Kanagasabai T, Lu W, Brown L Sci Signal. 2024; 17(867):eadk4122.

PMID: 39689183 PMC: 11784317. DOI: 10.1126/scisignal.adk4122.

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death.

Saqirile , Deng Y, Li K, Yan W, Li K, Wang C Curr Issues Mol Biol. 2024; 46(9):10264-10298.

PMID: 39329964 PMC: 11430711. DOI: 10.3390/cimb46090612.

Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy.

Qian J, Zhao L, Xu L, Zhao J, Tang Y, Yu M Int J Mol Sci. 2024; 25(17).

PMID: 39273650 PMC: 11395276. DOI: 10.3390/ijms25179703.

References

Dobrovic A, Simpfendorfer D . Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 1997; 57(16):3347-50. View

Thor A, Moore DH I, Edgerton S, Kawasaki E, Reihsaus E, Lynch H . Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst. 1992; 84(11):845-55. DOI: 10.1093/jnci/84.11.845. View

Welcsh P, OWENS K, King M . Insights into the functions of BRCA1 and BRCA2. Trends Genet. 2000; 16(2):69-74. DOI: 10.1016/s0168-9525(99)01930-7. View

Gowen L, Avrutskaya A, Latour A, Koller B, Leadon S . BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science. 1998; 281(5379):1009-12. DOI: 10.1126/science.281.5379.1009. View

Furuya D, Tsuji N, Yagihashi A, Watanabe N . Beclin 1 augmented cis-diamminedichloroplatinum induced apoptosis via enhancing caspase-9 activity. Exp Cell Res. 2005; 307(1):26-40. DOI: 10.1016/j.yexcr.2005.02.023. View

Miremadi A, Oestergaard M, Pharoah P, Caldas C . Cancer genetics of epigenetic genes. Hum Mol Genet. 2007; 16 Spec No 1:R28-49. DOI: 10.1093/hmg/ddm021. View

Wilson F, Kahle K, Sabath E, Lalioti M, Rapson A, Hoover R . Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A. 2003; 100(2):680-4. PMC: 141056. DOI: 10.1073/pnas.242735399. View

Esteller M, Corn P, Baylin S, Herman J . A gene hypermethylation profile of human cancer. Cancer Res. 2001; 61(8):3225-9. View

Wilson C, Ramos L, Villasenor M, Anders K, Press M, Clarke K . Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet. 1999; 21(2):236-40. DOI: 10.1038/6029. View

10.

Coles C, Condie A, Chetty U, Steel C, Evans H, Prosser J . p53 mutations in breast cancer. Cancer Res. 1992; 52(19):5291-8. View

11.

Xu X, Wagner K, Larson D, Weaver Z, Li C, Ried T . Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 1999; 22(1):37-43. DOI: 10.1038/8743. View

12.

Liang X, Kleeman L, Jiang H, Gordon G, Goldman J, Berry G . Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998; 72(11):8586-96. PMC: 110269. DOI: 10.1128/JVI.72.11.8586-8596.1998. View

13.

Edinger A, Thompson C . Defective autophagy leads to cancer. Cancer Cell. 2004; 4(6):422-4. DOI: 10.1016/s1535-6108(03)00306-4. View

14.

Unoki M, Nakamura Y . Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity. FEBS Lett. 2003; 554(1-2):67-72. DOI: 10.1016/s0014-5793(03)01092-5. View

15.

Klionsky D, Emr S . Autophagy as a regulated pathway of cellular degradation. Science. 2000; 290(5497):1717-21. PMC: 2732363. DOI: 10.1126/science.290.5497.1717. View

16.

Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996; 93(18):9821-6. PMC: 38513. DOI: 10.1073/pnas.93.18.9821. View

17.

Roessler M, Rollinger W, Mantovani-Endl L, Hagmann M, Palme S, Berndt P . Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics. 2006; 5(11):2092-101. DOI: 10.1074/mcp.M600118-MCP200. View

18.

Zhang Q, Mashima Y, Noda S, Imamura Y, Kudoh J, Shimizu N . Characterization of AOC2 gene encoding a copper-binding amine oxidase expressed specifically in retina. Gene. 2003; 318:45-53. DOI: 10.1016/s0378-1119(03)00753-4. View

19.

Liang X, Yu J, Brown K, Levine B . Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res. 2001; 61(8):3443-9. View

20.

Lakhani S, Jacquemier J, Sloane J, Gusterson B, Anderson T, van de Vijver M . Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998; 90(15):1138-45. DOI: 10.1093/jnci/90.15.1138. View